Molecular Imaging Program, National Cancer Institute, Bethesda, Maryland.
Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland.
J Urol. 2012 Oct;188(4):1157-1163. doi: 10.1016/j.juro.2012.06.011. Epub 2012 Aug 15.
The biology of prostate cancer may be influenced by the index lesion. The definition of index lesion volume is important for appropriate decision making, especially for image guided focal treatment. We determined the accuracy of magnetic resonance imaging for determining index tumor volume compared with volumes derived from histopathology.
We evaluated 135 patients (mean age 59.3 years) with a mean prostate specific antigen of 6.74 ng/dl who underwent multiparametric 3T endorectal coil magnetic resonance imaging of the prostate and subsequent radical prostatectomy. Index tumor volume was determined prospectively and independently by magnetic resonance imaging and histopathology. The ellipsoid formula was applied to determine histopathology tumor volume, whereas manual tumor segmentation was used to determine magnetic resonance tumor volume. Histopathology tumor volume was correlated with age and prostate specific antigen whereas magnetic resonance tumor volume involved Pearson correlation and linear regression methods. In addition, the predictive power of magnetic resonance tumor volume, prostate specific antigen and age for estimating histopathology tumor volume (greater than 0.5 cm(3)) was assessed by ROC analysis. The same analysis was also conducted for the 1.15 shrinkage factor corrected histopathology data set.
There was a positive correlation between histopathology tumor volume and magnetic resonance tumor volume (Pearson coefficient 0.633, p <0.0001), but a weak correlation between prostate specific antigen and histopathology tumor volume (Pearson coefficient 0.237, p = 0.003). On linear regression analysis histopathology tumor volume and magnetic resonance tumor volume were correlated (r(2) = 0.401, p <0.00001). On ROC analysis AUC values for magnetic resonance tumor volume, prostate specific antigen and age in estimating tumors larger than 0.5 cm(3) at histopathology were 0.949 (p <0.0000001), 0.685 (p = 0.001) and 0.627 (p = 0.02), respectively. Similar results were found in the analysis with shrinkage factor corrected tumor volumes at histopathology.
Magnetic resonance imaging can accurately estimate index tumor volume as determined by histology. Magnetic resonance imaging has better accuracy in predicting histopathology tumor volume in tumors larger than 0.5 cm(3) than prostate specific antigen and age. Index tumor volume as determined by magnetic resonance imaging may be helpful in planning treatment, specifically in identifying tumor margins for image guided focal therapy and possibly selecting better active surveillance candidates.
前列腺癌的生物学特性可能受起始肿瘤的影响。起始肿瘤体积的定义对于适当的决策很重要,特别是对于图像引导的局部治疗。我们评估了 135 例患者(平均年龄 59.3 岁,平均 PSA 为 6.74ng/dl),这些患者均接受了多参数 3T 直肠内线圈磁共振成像检查,随后接受了根治性前列腺切除术。前瞻性地通过磁共振成像和组织病理学独立确定起始肿瘤体积。应用椭圆公式确定组织病理学肿瘤体积,而手动肿瘤分割用于确定磁共振肿瘤体积。组织病理学肿瘤体积与年龄和 PSA 相关,而磁共振肿瘤体积则涉及 Pearson 相关和线性回归方法。此外,还通过 ROC 分析评估了磁共振肿瘤体积、PSA 和年龄预测组织病理学肿瘤体积(大于 0.5cm3)的能力。还对 1.15 收缩因子校正的组织病理学数据集进行了相同的分析。
组织病理学肿瘤体积与磁共振肿瘤体积之间存在正相关(Pearson 系数为 0.633,p<0.0001),但 PSA 与组织病理学肿瘤体积之间存在弱相关(Pearson 系数为 0.237,p=0.003)。线性回归分析显示,组织病理学肿瘤体积和磁共振肿瘤体积相关(r2=0.401,p<0.00001)。在 ROC 分析中,磁共振肿瘤体积、PSA 和年龄预测组织学上大于 0.5cm3 的肿瘤的 AUC 值分别为 0.949(p<0.0000001)、0.685(p=0.001)和 0.627(p=0.02)。在对组织学上用收缩因子校正的肿瘤体积进行分析时,也得到了类似的结果。
磁共振成像可以准确估计组织学确定的起始肿瘤体积。磁共振成像在预测组织学上大于 0.5cm3 的肿瘤的肿瘤体积方面比 PSA 和年龄具有更高的准确性。磁共振成像确定的起始肿瘤体积有助于治疗计划,特别是确定图像引导的局部治疗的肿瘤边界,并可能选择更好的主动监测候选者。